Insider Trading › TAK › Insiders
TAKEDA PHARMACEUTICAL CO LTD
TAK·NYSE·
Japan·Insider activity
Japan·Insider activity$18.10
+0.29 (+1.63%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
TAK
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
TAKS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, TAK insiders filed 0 purchases ($0) and 20 sales ($4.4M) on the open market, by 13 insiders. Newest filing Sep 15, 2026 (22 days ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by TAK insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$4.4MSales · 180 days
20Open-market transactions on record
13Insiders filing · 180 days
Purchases (code P) and sales (code S) of TAK common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
20 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Duprey Lauren RusckowskiChief Transformation Officer | Sale | −34.5K | $18.54 | $640K | 191.5Kdirect | Sep 14, 2026 | Sep 15, 2026 | Form 4 ↗ |
| Plump Andrew StewartPresident, R&D · Director | Sale | −116.2K | $18.49 | $2.1M | 145.5Kindirect | Sep 2, 2026 | Sep 3, 2026 | Form 4 ↗ |
| Plump Andrew StewartPresident, R&D · Director | Sale | −19.7K | $18.49 | $363K | 261.7Kindirect | Aug 19, 2026 | Aug 21, 2026 | Form 4 ↗ |
| Greenway Nicola Deidre PetalChief Human Resources Officer | Sale | −13.0K | $18.11 | $235K | 40.0Kdirect | Aug 18, 2026 | Aug 19, 2026 | Form 4 ↗ |
| Shannon Elaine MaryPres., Global Supply & Quality | Sale | −20.4K | $17.55 | $357K | 67.3Kdirect | Aug 11, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Farajallah Awny Samaan BotrosChief Medical Officer | Sale | −14.0K | n/c | — | 116.2Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Ibrahim Ramy Riad AhmedPresident, PDT BU | Sale | −7,277 | n/c | — | 102.6Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Pacheco Rhonda JanicePresident, U.S. Business Unit | Sale | −16.9K | n/c | — | 182.5Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Duprey Lauren RusckowskiChief Transformation Officer | Sale | −47.6K | n/c | — | 226.1Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Plump Andrew StewartPresident, R&D · Director | Sale | −165.4K | n/c | — | 766.6Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev | Sale | −23.0K | n/c | — | 177.0Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Bitetti Teresa MariePresident, OBU | Sale | −50.0K | n/c | — | 252.0Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Shannon Elaine MaryPres., Global Supply & Quality | Sale | −3,978 | n/c | — | 63.3Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Ricci GabrieleChief Data & Tech. Officer | Sale | −25.1K | n/c | — | 171.7Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Greenway Nicola Deidre PetalChief Human Resources Officer | Sale | −6,774 | n/c | — | 53.0Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Kim Julie So-YoungPresident and CEO · Director | Sale | −89.1K | n/c | — | 391.5Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Platford Giles RichardPresident, IBU | Sale | −31.1K | n/c | — | 315.8Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Furney Natalie Anne MarieGlobal General Counsel | Sale | −30.9K | n/c | — | 204.3Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Greenway Nicola Deidre PetalChief Human Resources Officer | Sale | −975 | $17.50 | $17K | 93.4Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Greenway Nicola Deidre PetalChief Human Resources Officer | Sale | −33.6K | $17.51 | $589K | 59.8Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →